Antipsychotic focus to PSA Refresher Course

To many pharmacists and GPs, antipsychotics are something of a mystery.

But for pharmacists attending the PSA Offshore Refresher Conference this year, help is at hand.

Professor Andrew McLachlan, education director of the conference, will present some simple rules to help understand the differences and similarities of conventional and atypical antipsychotics.

It will be explained that the CATIE study showed there were no differences in symptom scores and quality-of-life measures between most antipsychotics; however there are differences between safety and tolerability and have a greater impact on therapy than any difference in efficacy.

Because of these substantial adverse effects, non-adherence is a common cause of treatment failure and pharmacists have an important role in assisting patients cope with the adverse affects including weight gain,...

This site is intended for Registered Medical Practitioners.

To make the most of Pharmacy News, you need to be logged in.

Related articles

1 in 16 Has Anaphylaxis History (CME/CE)
Vomaris appoints Michael Nagel as new CEO
Can acne medication be the cause of this?
ABILIFY OVERDOSE ALCOHOL IBUPROFEN! HELP.
Smith & Nephew PICO system wins FDA nod